Over the past few decades, we have made significant progress against many forms of cancer. Today, there are nearly 14 million cancer survivors living in the United States, 15 percent of whom were diagnosed 20 or more years ago. There have also been more than 1 million fewer cancer deaths since the early 1990s as a result of declining death rates from cancer.
Perhaps the most compelling, as well as the least understood of the evolving models for cancer research and care is patient-centered research and care. As a cancer survivor and long-time advocate, I am often asked to provide the patient perspective in the various venues where patient-centered issues are discussed.
We are now in an era of incredible scientific progress, where our understanding of the molecular underpinnings of disease enables scientists and researchers to develop treatments that are more targeted and precise in their impact. As highlighted in a blog post by Dr. Raju Kucherlapati from Harvard, oncology is at the leading edge of advances in personalized medicine, offering patients better options that deliver improved health outcomes.